MX2011010634A - Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. - Google Patents

Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa.

Info

Publication number
MX2011010634A
MX2011010634A MX2011010634A MX2011010634A MX2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A
Authority
MX
Mexico
Prior art keywords
monoclonal antibody
human monoclonal
lipopolysaccarides
lps
antibody specific
Prior art date
Application number
MX2011010634A
Other languages
English (en)
Inventor
Michael Rudolf
Holger Koch
Stefanie Fas
Original Assignee
Kenta Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenta Biotech Ag filed Critical Kenta Biotech Ag
Publication of MX2011010634A publication Critical patent/MX2011010634A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Abstract

La presente invención se refiere a un anticuerpo monoclonal humano específico para el serotipo IATS 01 de P. aeruginosa, y un hibridoma que produce dicho anticuerpo monoclonal. Además, la presente invención se refiere a composiciones farmacéuticas que comprenden por lo menos un anticuerpo o por lo menos un ácido nucleico que codifica dicho anticuerpo.
MX2011010634A 2009-04-09 2010-04-06 Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. MX2011010634A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09005245 2009-04-09
PCT/EP2010/002158 WO2010115606A1 (en) 2009-04-09 2010-04-06 Human monoclonal antibody specific for lipopolysaccarides (lps) of serotype iats 01 of pseudomonas aeruginosa

Publications (1)

Publication Number Publication Date
MX2011010634A true MX2011010634A (es) 2012-03-06

Family

ID=40934847

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010634A MX2011010634A (es) 2009-04-09 2010-04-06 Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa.

Country Status (10)

Country Link
US (1) US20120114657A1 (es)
EP (1) EP2417157A1 (es)
JP (1) JP2012523221A (es)
KR (1) KR20120016086A (es)
CN (1) CN102639562A (es)
BR (1) BRPI1013427A2 (es)
CA (1) CA2758081A1 (es)
IL (1) IL215549A0 (es)
MX (1) MX2011010634A (es)
WO (1) WO2010115606A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102858977A (zh) * 2010-02-18 2013-01-02 明治制果药业株式会社 铜绿假单胞菌g血清型脂多糖抗体
CA2838211C (en) * 2011-06-10 2023-08-01 Medimmmune Limited Anti-pseudomonas psl binding molecules and uses thereof
EP2776065B1 (en) 2011-11-07 2020-08-05 MedImmune Limited Combination therapies using anti- pseudomonas psl and pcrv binding molecules
AU2016353073A1 (en) 2015-11-10 2018-06-07 Visterra, Inc. Antibody molecule-drug conjugates that specifically binds to lipopolysaccharide and uses thereof
CA3049449A1 (en) 2017-01-18 2018-07-26 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834975A (en) 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US5955584A (en) * 1986-03-31 1999-09-21 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
ATE458006T1 (de) * 2003-05-14 2010-03-15 Kenta Biotech Ag Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype

Also Published As

Publication number Publication date
WO2010115606A1 (en) 2010-10-14
KR20120016086A (ko) 2012-02-22
JP2012523221A (ja) 2012-10-04
BRPI1013427A2 (pt) 2016-04-05
IL215549A0 (en) 2011-12-29
CN102639562A (zh) 2012-08-15
EP2417157A1 (en) 2012-02-15
CA2758081A1 (en) 2010-10-14
US20120114657A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
SG178886A1 (en) Humanized anti-cdcp1 antibodies
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
NZ594315A (en) Antibody molecules having specificity for human ox40
UA101487C2 (en) Humanized b-ly1 antibody formulation
IN2012DN00797A (es)
MY178926A (en) Bispecific anti-vegf/anti-ang-2 antibodies
MY160736A (en) Bivalent, bispecific antibodies
WO2009083009A3 (en) Monoclonal antibodies against cd32b
UA109658C2 (xx) Антитіло проти cgrp
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
WO2009061996A3 (en) Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
WO2011147982A3 (en) Monoclonal antibodies against her2 epitope
MX2010004482A (es) Anticuerpos anti-proteina g vsr.
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
MX355181B (es) Anticuerpos humanos contra el factor tisular.
AU2016219704A1 (en) Anti-Notch1 antibodies
MX2011010634A (es) Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa.
MX347978B (es) Uso de los anticuerpos anti-il-17a y anti-il-17f en el tratamiento de la resistentes a insulina.
IL184774A0 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats 011 serotype
WO2009035959A3 (en) Radiofluorination methods

Legal Events

Date Code Title Description
FA Abandonment or withdrawal